Akshat Jain: Key Takeaways from ASH2025: Transformative Therapeutics, Global Insight, and Compassionate Innovation
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:
“What an inspiring week at ASH2025 — the American Society of Hematology annual meeting in Orlando! Every year, this meeting reinforces why hematology is the beating heart of translational medicine. A few key takeaways that deeply resonated:
Transformative Therapeutics: The science behind novel agents continues to redefine how we treat human disease. The precision and creativity developed in blood disorders are now paving the way for breakthroughs across cancer, autoimmune, and metabolic diseases — a thrilling horizon for modern medicine.
Bench to Bedside in Action: Seeing how complex, chronic, and rare diseases are being approached with structured, risk-adapted protocols reminds me how rigor and compassion come together in true clinical innovation.
Industry: bouncing off ideas , laying Foundation for new collaborations and learning about pipeline always invigorate me.
Global Health Perspective: Hearing insights from colleagues across Europe, Asia, Africa, and beyond was humbling. The diversity in strategy, resource utilization, and patient response reminds us that innovation thrives when we listen, learn, and adapt globally.
Community and Collaboration: The best part — reconnecting with mentors, peers, and new collaborators. The exchange of ideas and the spark of potential partnerships always reignite my passion for research and patient care.
Grateful to be part of a field where discovery meets compassion every single day.
Thank you Andrea Fischer for keeping us informed and an amazing meeting.
Hemostasis Today, American Society of Clinical Oncology (ASCO), Blood Journals Portfolio bringing out timely reading.”
Stay updated with ASH25 updates with Hemostasis Today.
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
-
Mar 16, 2026, 15:53Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
-
Mar 16, 2026, 15:44Francis Kynaston-Pearson: Why Randomised Controlled Trials Are the Gold Standard in Clinical Research
-
Mar 16, 2026, 15:18Kalpana Gupta Shekhawat: A Practical Clinical Approach to Iron Regulation